Global Nanotechnology Drug Delivery Systems Market Growth, Trends, and Forecasts 2015-2025

  • receipt Report ID : 60070
  • calendar_today Published On: May, 2020
  • file_copy Pages: 110
  • list Pharmaceuticals and Healthcare
Buy @ $3660

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Nanotechnology Drug Delivery Systems will have significant change from previous year. By the most conservative estimates of global Nanotechnology Drug Delivery Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Nanotechnology Drug Delivery Systems market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Nanotechnology Drug Delivery Systems market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Nanotechnology Drug Delivery Systems, covering the supply chain analysis, impact assessment to the Nanotechnology Drug Delivery Systems market size growth rate in several scenarios, and the measures to be undertaken by Nanotechnology Drug Delivery Systems companies in response to the COVID-19 epidemic.

Segmentation by product type:

Nanocrystals

Nanoparticles

Dendrimers

Gold Nanoparticles

Fullerenes

Liposomes

Nanotubes

Others

Segmentation by Application

Immunology

Cardiovascular

Neurology

Oncology

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

Rest of Americas

APAC

China

Japan

Korea

Taiwan

India

Australia

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Rest of APAC

Europe

Germany

France

UK

Russia

Italy

Benelux

Nordic

Rest of Europe

MENA

Saudi Arabia

UAE

Turkey

South Africa

Egypt

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.

AbbVie, Inc.

3M

Amgen Inc.

Johnson & Johnson

Merck & Co., Inc.

Celgene Corporation

Pfizer, Inc.

Novartis International AG

Teva Pharmaceutical Industries Ltd.

Perrigo Company plc

Nitto

TheraJect

Microdermics

Zosano Pharma

Corium

Nanopass Technologies

Lohmann Therapie-Systeme AG

Valeritas

Becton-Dickinson_BD_Technologies

Vaxxas

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

1.7 What is the Impact of Covid-19 Outbreak On the Nanotechnology Drug Delivery Systems?

1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.

1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.

1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Nanotechnology Drug Delivery Systems Market Size in 2020, by Scenario

1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary

2.1 Market Overview

2.1.1 Global Nanotechnology Drug Delivery Systems Market Size and Forecast, 2015-2025

2.1.2 Nanotechnology Drug Delivery Systems Market Size and Forecast by Region, 2015 VS 2020 VS 2025

2.2 Global Nanotechnology Drug Delivery Systems Market Size and Forecast by Regions, 2015-2025 ($ millions)

2.3 Americas Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

2.4 APAC Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

2.5 Europe Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

2.6 MENA Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

3 Nanotechnology Drug Delivery Systems Market Size by Player

3.1 Global Nanotechnology Drug Delivery Systems Market Size by Player

3.1.1 Global Top Players Nanotechnology Drug Delivery Systems Revenue, 2018-2020E ($ millions)

3.1.2 Global Top Nanotechnology Drug Delivery Systems Players Market Share, 2018-2020E

3.2 Global Key Nanotechnology Drug Delivery Systems Players Rank in 2019

3.3 Global Key Nanotechnology Drug Delivery Systems Players Head office and Products Offered

3.4 Market Concentration Rate Analysis

3.4.1 Competition Landscape Analysis

3.4.2 Concentration Ratio (CR3, CR5 and CR10), 2018-2020E

3.5 New Products and Potential Entrants

3.6 Mergers & Acquisitions, Expansion

4 Nanotechnology Drug Delivery Systems Segment by Type

4.1 Overview

4.1.1 Nanocrystals

4.1.2 Nanoparticles

4.1.3 Dendrimers

4.1.4 Gold Nanoparticles

4.1.5 Fullerenes

4.1.6 Liposomes

4.1.7 Nanotubes

4.1.8 Others

4.2 Global Nanotechnology Drug Delivery Systems Market Size by Type, 2015-2025 ($ millions)

4.3 Nanocrystals Market Size by Region, 2015-2025 ($ millions)

4.4 Nanoparticles Market Size by Region, 2015-2025 ($ millions)

4.5 Dendrimers Market Size by Region, 2015-2025 ($ millions)

4.6 Gold Nanoparticles Market Size by Region, 2015-2025 ($ millions)

4.7 Fullerenes Market Size by Region, 2015-2025 ($ millions)

4.8 Liposomes Market Size by Region, 2015-2025 ($ millions)

4.9 Nanotubes Market Size by Region, 2015-2025 ($ millions)

4.10 Others Market Size by Region, 2015-2025 ($ millions)

5 Nanotechnology Drug Delivery Systems Segment by Application

5.1 Overview

5.1.1 Immunology

5.1.2 Cardiovascular

5.1.3 Neurology

5.1.4 Oncology

5.1.5 Others

5.2 Global Nanotechnology Drug Delivery Systems Market Size by Application, 2015-2025 ($ millions)

5.3 Immunology Market Size by Region, 2015-2025 ($ millions)

5.4 Cardiovascular Market Size by Region, 2015-2025 ($ millions)

5.5 Neurology Market Size by Region, 2015-2025 ($ millions)

5.6 Oncology Market Size by Region, 2015-2025 ($ millions)

5.7 Others Market Size by Region, 2015-2025 ($ millions)

6 Americas

6.1 Americas Nanotechnology Drug Delivery Systems Market Size by Country

6.2 United States Nanotechnology Drug Delivery Systems Market Size

6.3 Canada Nanotechnology Drug Delivery Systems Market Size

6.4 Mexico Nanotechnology Drug Delivery Systems Market Size

6.5 Brazil Nanotechnology Drug Delivery Systems Market Size

7 APAC

7.1 APAC Nanotechnology Drug Delivery Systems Market Size by Regions

7.2 China Nanotechnology Drug Delivery Systems Market Size

7.3 Japan Nanotechnology Drug Delivery Systems Market Size

7.4 Korea Nanotechnology Drug Delivery Systems Market Size

7.5 Taiwan Nanotechnology Drug Delivery Systems Market Size

7.6 India Nanotechnology Drug Delivery Systems Market Size

7.7 Australia Nanotechnology Drug Delivery Systems Market Size

7.8 Indonesia Nanotechnology Drug Delivery Systems Market Size

7.9 Thailand Nanotechnology Drug Delivery Systems Market Size

7.10 Malaysia Nanotechnology Drug Delivery Systems Market Size

7.11 Philippines Nanotechnology Drug Delivery Systems Market Size

7.12 Vietnam Nanotechnology Drug Delivery Systems Market Size

8 Europe

8.1 Europe Nanotechnology Drug Delivery Systems by Country

8.2 Germany Nanotechnology Drug Delivery Systems Market Size

8.3 France Nanotechnology Drug Delivery Systems Market Size

8.4 UK Nanotechnology Drug Delivery Systems Market Size

8.5 Russia Nanotechnology Drug Delivery Systems Market Size

8.6 Italy Nanotechnology Drug Delivery Systems Market Size

8.7 Australia Nanotechnology Drug Delivery Systems Market Size

8.8 Benelux Nanotechnology Drug Delivery Systems Market Size

8.9 Nordic Nanotechnology Drug Delivery Systems Market Size

9 MENA

9.1 MENA & Africa Nanotechnology Drug Delivery Systems by Country

9.2 Saudi Arabia Nanotechnology Drug Delivery Systems Market Size

9.3 UAE Nanotechnology Drug Delivery Systems Market Size

9.4 Turkey Nanotechnology Drug Delivery Systems Market Size

9.5 South Africa Nanotechnology Drug Delivery Systems Market Size

9.6 Egypt Nanotechnology Drug Delivery Systems Market Size

10 Market Drivers, Challenges and Trends

10.1 Market Drivers and Impact

10.1.1 Growing Demand from Key Regions

10.1.2 Growing Demand from Key Applications and Potential Industries

10.2 Market Challenges and Impact

10.3 Market Trends

11 Key Players Analysis

11.1 AbbVie, Inc.

11.1.1 AbbVie, Inc. Company Information

11.1.2 AbbVie, Inc. Nanotechnology Drug Delivery Systems Product Offered

11.1.3 AbbVie, Inc. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.1.4 AbbVie, Inc. Main Business Overview

11.1.5 AbbVie, Inc. Latest Developments

11.2 3M

11.2.1 3M Company Information

11.2.2 3M Nanotechnology Drug Delivery Systems Product Offered

11.2.3 3M Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.2.4 3M Main Business Overview

11.2.5 3M Latest Developments

11.3 Amgen Inc.

11.3.1 Amgen Inc. Company Information

11.3.2 Amgen Inc. Nanotechnology Drug Delivery Systems Product Offered

11.3.3 Amgen Inc. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.3.4 Amgen Inc. Main Business Overview

11.3.5 Amgen Inc. Latest Developments

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Information

11.4.2 Johnson & Johnson Nanotechnology Drug Delivery Systems Product Offered

11.4.3 Johnson & Johnson Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.4.4 Johnson & Johnson Main Business Overview

11.4.5 Johnson & Johnson Latest Developments

11.5 Merck & Co., Inc.

11.5.1 Merck & Co., Inc. Company Information

11.5.2 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Product Offered

11.5.3 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.5.4 Merck & Co., Inc. Main Business Overview

11.5.5 Merck & Co., Inc. Latest Developments

11.6 Celgene Corporation

11.6.1 Celgene Corporation Company Information

11.6.2 Celgene Corporation Nanotechnology Drug Delivery Systems Product Offered

11.6.3 Celgene Corporation Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.6.4 Celgene Corporation Main Business Overview

11.6.5 Celgene Corporation Latest Developments

11.7 Pfizer, Inc.

11.7.1 Pfizer, Inc. Company Information

11.7.2 Pfizer, Inc. Nanotechnology Drug Delivery Systems Product Offered

11.7.3 Pfizer, Inc. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.7.4 Pfizer, Inc. Main Business Overview

11.7.5 Pfizer, Inc. Latest Developments

11.8 Novartis International AG

11.8.1 Novartis International AG Company Information

11.8.2 Novartis International AG Nanotechnology Drug Delivery Systems Product Offered

11.8.3 Novartis International AG Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.8.4 Novartis International AG Main Business Overview

11.8.5 Novartis International AG Latest Developments

11.9 Teva Pharmaceutical Industries Ltd.

11.9.1 Teva Pharmaceutical Industries Ltd. Company Information

11.9.2 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Product Offered

11.9.3 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.9.4 Teva Pharmaceutical Industries Ltd. Main Business Overview

11.9.5 Teva Pharmaceutical Industries Ltd. Latest Developments

11.10 Perrigo Company plc

11.10.1 Perrigo Company plc Company Information

11.10.2 Perrigo Company plc Nanotechnology Drug Delivery Systems Product Offered

11.10.3 Perrigo Company plc Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.10.4 Perrigo Company plc Main Business Overview

11.10.5 Perrigo Company plc Latest Developments

11.11 Nitto

11.11.1 Nitto Company Information

11.11.2 Nitto Nanotechnology Drug Delivery Systems Product Offered

11.11.3 Nitto Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.11.4 Nitto Main Business Overview

11.11.5 Nitto Latest Developments

11.12 TheraJect

11.12.1 TheraJect Company Information

11.12.2 TheraJect Nanotechnology Drug Delivery Systems Product Offered

11.12.3 TheraJect Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.12.4 TheraJect Main Business Overview

11.12.5 TheraJect Latest Developments

11.13 Microdermics

11.13.1 Microdermics Company Information

11.13.2 Microdermics Nanotechnology Drug Delivery Systems Product Offered

11.13.3 Microdermics Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.13.4 Microdermics Main Business Overview

11.13.5 Microdermics Latest Developments

11.14 Zosano Pharma

11.14.1 Zosano Pharma Company Information

11.14.2 Zosano Pharma Nanotechnology Drug Delivery Systems Product Offered

11.14.3 Zosano Pharma Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.14.4 Zosano Pharma Main Business Overview

11.14.5 Zosano Pharma Latest Developments

11.15 Corium

11.15.1 Corium Company Information

11.15.2 Corium Nanotechnology Drug Delivery Systems Product Offered

11.15.3 Corium Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.15.4 Corium Main Business Overview

11.15.5 Corium Latest Developments

11.16 Nanopass Technologies

11.16.1 Nanopass Technologies Company Information

11.16.2 Nanopass Technologies Nanotechnology Drug Delivery Systems Product Offered

11.16.3 Nanopass Technologies Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.16.4 Nanopass Technologies Main Business Overview

11.16.5 Nanopass Technologies Latest Developments

11.17 Lohmann Therapie-Systeme AG

11.17.1 Lohmann Therapie-Systeme AG Company Information

11.17.2 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Product Offered

11.17.3 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.17.4 Lohmann Therapie-Systeme AG Main Business Overview

11.17.5 Lohmann Therapie-Systeme AG Latest Developments

11.18 Valeritas

11.18.1 Valeritas Company Information

11.18.2 Valeritas Nanotechnology Drug Delivery Systems Product Offered

11.18.3 Valeritas Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.18.4 Valeritas Main Business Overview

11.18.5 Valeritas Latest Developments

11.19 Becton-Dickinson_BD_Technologies

11.19.1 Becton-Dickinson_BD_Technologies Company Information

11.19.2 Becton-Dickinson_BD_Technologies Nanotechnology Drug Delivery Systems Product Offered

11.19.3 Becton-Dickinson_BD_Technologies Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.19.4 Becton-Dickinson_BD_Technologies Main Business Overview

11.19.5 Becton-Dickinson_BD_Technologies Latest Developments

11.20 Vaxxas

11.20.1 Vaxxas Company Information

11.20.2 Vaxxas Nanotechnology Drug Delivery Systems Product Offered

11.20.3 Vaxxas Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E

11.20.4 Vaxxas Main Business Overview

11.20.5 Vaxxas Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Nanotechnology Drug Delivery Systems Market Size in 2020, by Scenario

Table 2. COVID-19: Measures to be Undertaken by Nanotechnology Drug Delivery Systems Companies

Table 3. Research Methodology

Table 4. Data Source

Table 5. Nanotechnology Drug Delivery Systems Market Size CAGR by Region 2015-2025 ($ Millions)

Table 6. Global Nanotechnology Drug Delivery Systems Market Size by Regions, 2015-2025 ($ millions)

Table 7. Global Nanotechnology Drug Delivery Systems Market Size Share by Regions, 2015-2025

Table 8. Global Nanotechnology Drug Delivery Systems Revenue by Player, 2018-2020E ($ millions)

Table 9. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Player, 2018-2020E

Table 10. Global Key Nanotechnology Drug Delivery Systems Players Rank in 2019, Based on the Revenue in Nanotechnology Drug Delivery Systems

Table 11. Global Key Nanotechnology Drug Delivery Systems Players Head office and Products Offered

Table 12. Nanotechnology Drug Delivery Systems Concentration Ratio (CR3, CR5 and CR10), 2018-2020E

Table 13. New Products and Potential Entrants

Table 14. Mergers & Acquisitions, Expansion

Table 15. Major Players of Nanocrystals

Table 16. Major Players of Nanoparticles

Table 17. Major Players of Dendrimers

Table 18. Major Players of Gold Nanoparticles

Table 19. Major Players of Fullerenes

Table 20. Major Players of Liposomes

Table 21. Major Players of Nanotubes

Table 22. Major Players of Others

Table 23. Global Nanotechnology Drug Delivery Systems Market Size CAGR by Type ($ millions): 2015 VS 2020 VS 2025

Table 24. Global Nanotechnology Drug Delivery Systems Market Size by Type, 2015-2025 ($ millions)

Table 25. Global Nanotechnology Drug Delivery Systems Market Size Share by Type, 2015-2025

Table 26. Global Nanocrystals Market Size by Region, 2015-2025 ($ millions)

Table 27. Global Nanocrystals Market Size Share by Region, 2015-2025

Table 28. Global Nanoparticles Market Size by Region, 2015-2025 ($ millions)

Table 29. Global Nanoparticles Market Size Share by Region, 2015-2025

Table 30. Global Dendrimers Market Size by Region, 2015-2025 ($ millions)

Table 31. Global Dendrimers Market Size Share by Region, 2015-2025

Table 32. Global Gold Nanoparticles Market Size by Region, 2015-2025 ($ millions)

Table 33. Global Gold Nanoparticles Market Size Share by Region, 2015-2025

Table 34. Global Fullerenes Market Size by Region, 2015-2025 ($ millions)

Table 35. Global Fullerenes Market Size Share by Region, 2015-2025

Table 36. Global Liposomes Market Size by Region, 2015-2025 ($ millions)

Table 37. Global Liposomes Market Size Share by Region, 2015-2025

Table 38. Global Nanotubes Market Size by Region, 2015-2025 ($ millions)

Table 39. Global Nanotubes Market Size Share by Region, 2015-2025

Table 40. Global Others Market Size by Region, 2015-2025 ($ millions)

Table 41. Global Others Market Size Share by Region, 2015-2025

Table 42. Global Nanotechnology Drug Delivery Systems Market Size CAGR by Application ($ millions): 2015 VS 2020 VS 2025

Table 43. Global Nanotechnology Drug Delivery Systems Market Size by Application, 2015-2025 ($ millions)

Table 44. Global Nanotechnology Drug Delivery Systems Market Size Share by Application, 2015-2025

Table 45. Global Immunology Market Size by Region, 2015-2025 ($ millions)

Table 46. Global Immunology Market Size Share by Region, 2015-2025

Table 47. Global Cardiovascular Market Size by Region, 2015-2025 ($ millions)

Table 48. Global Cardiovascular Market Size Share by Region, 2015-2025

Table 49. Global Neurology Market Size by Region, 2015-2025 ($ millions)

Table 50. Global Neurology Market Size Share by Region, 2015-2025

Table 51. Global Oncology Market Size by Region, 2015-2025 ($ millions)

Table 52. Global Oncology Market Size Share by Region, 2015-2025

Table 53. Global Others Market Size by Region, 2015-2025 ($ millions)

Table 54. Global Others Market Size Share by Region, 2015-2025

Table 55. Americas Nanotechnology Drug Delivery Systems Market Size by Country (2015-2020) ($ Millions)

Table 56. Americas Nanotechnology Drug Delivery Systems Market Size Share by Countries (2015-2020)

Table 57. APAC Nanotechnology Drug Delivery Systems Market Size by Region (2015-2020) ($ Millions)

Table 58. APAC Nanotechnology Drug Delivery Systems Market Size Share by Region (2015-2020)

Table 59. Europe Nanotechnology Drug Delivery Systems Market Size by Country (2015-2020) ($ Millions)

Table 60. Europe Nanotechnology Drug Delivery Systems Market Size Share by Country (2015-2020)

Table 61. MENA Nanotechnology Drug Delivery Systems Market Size by Country (2015-2020) ($ Millions)

Table 62. MENA Nanotechnology Drug Delivery Systems Market Size Share by Country (2015-2020)

Table 63. Key and Potential Regions of Nanotechnology Drug Delivery Systems

Table 64. Key Application and Potential Industries of Nanotechnology Drug Delivery Systems

Table 65. Key Challenges of Nanotechnology Drug Delivery Systems

Table 66. Key Trends of Nanotechnology Drug Delivery Systems

Table 67. AbbVie, Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 68. AbbVie, Inc. Nanotechnology Drug Delivery Systems Product Offered

Table 69. AbbVie, Inc. Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 70. AbbVie, Inc. Main Business

Table 71. AbbVie, Inc. Latest Developments

Table 72. 3M Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 73. 3M Nanotechnology Drug Delivery Systems Product Offered

Table 74. 3M Main Business

Table 75. 3M Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 76. 3M Latest Developments

Table 77. Amgen Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 78. Amgen Inc. Nanotechnology Drug Delivery Systems Product Offered

Table 79. Amgen Inc. Main Business

Table 80. Amgen Inc. Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 81. Amgen Inc. Latest Developments

Table 82. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 83. Johnson & Johnson Nanotechnology Drug Delivery Systems Product Offered

Table 84. Johnson & Johnson Main Business

Table 85. Johnson & Johnson Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 86. Johnson & Johnson Latest Developments

Table 87. Merck & Co., Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 88. Merck & Co., Inc. Nanotechnology Drug Delivery Systems Product Offered

Table 89. Merck & Co., Inc. Main Business

Table 90. Merck & Co., Inc. Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 91. Merck & Co., Inc. Latest Developments

Table 92. Celgene Corporation Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 93. Celgene Corporation Nanotechnology Drug Delivery Systems Product Offered

Table 94. Celgene Corporation Main Business

Table 95. Celgene Corporation Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 96. Celgene Corporation Latest Developments

Table 97. Pfizer, Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 98. Pfizer, Inc. Nanotechnology Drug Delivery Systems Product Offered

Table 99. Pfizer, Inc. Main Business

Table 100. Pfizer, Inc. Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 101. Pfizer, Inc. Latest Developments

Table 102. Novartis International AG Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 103. Novartis International AG Nanotechnology Drug Delivery Systems Product Offered

Table 104. Novartis International AG Main Business

Table 105. Novartis International AG Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 106. Novartis International AG Latest Developments

Table 107. Teva Pharmaceutical Industries Ltd. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 108. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Product Offered

Table 109. Teva Pharmaceutical Industries Ltd. Main Business

Table 110. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 111. Teva Pharmaceutical Industries Ltd. Latest Developments

Table 112. Perrigo Company plc Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 113. Perrigo Company plc Nanotechnology Drug Delivery Systems Product Offered

Table 114. Perrigo Company plc Main Business

Table 115. Perrigo Company plc Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 116. Perrigo Company plc Latest Developments

Table 117. Nitto Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 118. Nitto Nanotechnology Drug Delivery Systems Product Offered

Table 119. Nitto Main Business

Table 120. Nitto Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 121. Nitto Latest Developments

Table 122. TheraJect Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 123. TheraJect Nanotechnology Drug Delivery Systems Product Offered

Table 124. TheraJect Main Business

Table 125. TheraJect Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 126. TheraJect Latest Developments

Table 127. Microdermics Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 128. Microdermics Nanotechnology Drug Delivery Systems Product Offered

Table 129. Microdermics Main Business

Table 130. Microdermics Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 131. Microdermics Latest Developments

Table 132. Zosano Pharma Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 133. Zosano Pharma Nanotechnology Drug Delivery Systems Product Offered

Table 134. Zosano Pharma Main Business

Table 135. Zosano Pharma Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 136. Zosano Pharma Latest Developments

Table 137. Corium Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 138. Corium Nanotechnology Drug Delivery Systems Product Offered

Table 139. Corium Main Business

Table 140. Corium Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 141. Corium Latest Developments

Table 142. Nanopass Technologies Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 143. Nanopass Technologies Nanotechnology Drug Delivery Systems Product Offered

Table 144. Nanopass Technologies Main Business

Table 145. Nanopass Technologies Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 146. Nanopass Technologies Latest Developments

Table 147. Lohmann Therapie-Systeme AG Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 148. Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Product Offered

Table 149. Lohmann Therapie-Systeme AG Main Business

Table 150. Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 151. Lohmann Therapie-Systeme AG Latest Developments

Table 152. Valeritas Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 153. Valeritas Nanotechnology Drug Delivery Systems Product Offered

Table 154. Valeritas Main Business

Table 155. Valeritas Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 156. Valeritas Latest Developments

Table 157. Becton-Dickinson_BD_Technologies Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 158. Becton-Dickinson_BD_Technologies Nanotechnology Drug Delivery Systems Product Offered

Table 159. Becton-Dickinson_BD_Technologies Main Business

Table 160. Becton-Dickinson_BD_Technologies Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 161. Becton-Dickinson_BD_Technologies Latest Developments

Table 162. Vaxxas Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors

Table 163. Vaxxas Nanotechnology Drug Delivery Systems Product Offered

Table 164. Vaxxas Main Business

Table 165. Vaxxas Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E

Table 166. Vaxxas Latest Developments

List of Figures

Figure 1. Nanotechnology Drug Delivery Systems Report Years Considered

Figure 2. Global Nanotechnology Drug Delivery Systems Market Size Growth Rate, 2015-2025 ($ millions)

Figure 3. Nanotechnology Drug Delivery Systems Consumption by Region (2015 VS 2020 & 2025) ($ millions)

Figure 4. Global Nanotechnology Drug Delivery Systems Market Size Share by Regions, 2015-2025

Figure 5. Americas Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 6. APAC Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 7. Europe Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 8. MENA Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 9. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Player in 2019

Figure 10. Global Nanotechnology Drug Delivery Systems Market Size Share by Type in 2019

Figure 11. Nanotechnology Drug Delivery Systems in Immunology

Figure 12. Global Nanotechnology Drug Delivery Systems Market Size YoY Growth: Immunology, 2015-2025 ($ millions)

Figure 13. Nanotechnology Drug Delivery Systems in Cardiovascular

Figure 14. Global Nanotechnology Drug Delivery Systems Market Size YoY Growth: Cardiovascular, 2015-2025 ($ millions)

Figure 15. Nanotechnology Drug Delivery Systems in Neurology

Figure 16. Global Nanotechnology Drug Delivery Systems Market Size YoY Growth: Neurology, 2015-2025 ($ millions)

Figure 17. Nanotechnology Drug Delivery Systems in Oncology

Figure 18. Global Nanotechnology Drug Delivery Systems Market Size YoY Growth: Oncology, 2015-2025 ($ millions)

Figure 19. Nanotechnology Drug Delivery Systems in Others

Figure 20. Global Nanotechnology Drug Delivery Systems Market Size YoY Growth: Others, 2015-2025 ($ millions)

Figure 21. Americas Nanotechnology Drug Delivery Systems Value Market Share by Country in 2019

Figure 22. United States Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 23. Canada Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 24. Mexico Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 25. Brazil Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 26. APAC Nanotechnology Drug Delivery Systems Value Market Share by Region in 2019

Figure 27. China Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 28. Japan Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 29. Korea Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 30. Taiwan Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 31. India Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 32. Australia Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 33. Indonesia Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 34. Thailand Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 35. Malaysia Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 36. Philippines Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 37. Vietnam Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 38. Europe Nanotechnology Drug Delivery Systems Value Market Share by Country in 2019

Figure 39. Germany Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 40. France Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 41. UK Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 42. Russia Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 43. Italy Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 44. Australia Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 45. Benelux Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 46. Nordic Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 47. MENA Nanotechnology Drug Delivery Systems Value Market Share by Country in 2019

Figure 48. Saudi Arabia Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 49. UAE Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 50. Turkey Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 51. South Africa Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)

Figure 52. Egypt Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)